FGL-2 deletion (FGL-2-/-) leads to modulation of mouse aortic endothelial cells(MAECs) in an in vitro model of acute vascular xenograft rejection (AVR)

被引：0
|
作者：
Mendicino, M [1 ]
Vlasova, K [1 ]
Fung, L [1 ]
Marsden, P [1 ]
Phillips, MJ [1 ]
Waddell, T [1 ]
Grant, D [1 ]
Levy, GA [1 ]
机构：
[1] Toronto Gen Hosp, Toronto, ON, Canada
来源：
XENOTRANSPLANTATION | 2003年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：507 / 507
页数：1
相关论文
共 9 条
  • [1] The involvement of the novel immune coagulant FGL-2 in thrombosis in acute vascular xenograft rejection (AVR)
    Mendicino, M
    Grant, D
    Fung, L
    He, W
    Phillips, MJ
    Marsden, P
    Levy, G
    XENOTRANSPLANTATION, 2001, 8 : 44 - 45
  • [2] Targeted deletion of fgl-2/fibroleukin in the donor modulates the immunologic response and acute vascular rejection (AVR) in cardiac xenografts
    Levy, G
    Mendicino, M
    Liu, MF
    Ghanekar, A
    He, W
    Turnbull, J
    Fung, L
    Sakamoto, S
    Marsden, P
    Waddell, T
    Phillips, MJ
    Grant, D
    FASEB JOURNAL, 2005, 19 (05): : A1439 - A1439
  • [3] Targeted deletion of Fgl-2/fibroleukin in the donor modulates the immunologic response and acute vascular rejection (AVR) in cardiac xenografts.
    Mendicino, M
    Liu, MF
    Ghanekhar, A
    He, W
    Turnbull, J
    Fung, LS
    Sakamoto, S
    Marsden, P
    Waddell, T
    Phillips, MJ
    Levy, G
    Grant, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 561 - 562
  • [4] Use of an FGL-2-/- cardiac xenograft as a donor abrogates thrombosis in acute vascular rejection (AVR) but leads to a novel accelerated cellular immune response and enhanced apoptosis
    Grant, D
    Fung, LS
    He, W
    Marsden, P
    Phillips, MJ
    Levy, G
    FASEB JOURNAL, 2003, 17 (05): : A795 - A795
  • [5] Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts
    Mendicino, M
    Liu, MF
    Ghanekar, A
    He, W
    Koscik, C
    Shalev, I
    Javadi, M
    Turnbull, J
    Chen, WH
    Fung, LS
    Sakamoto, S
    Marsden, P
    Waddell, TK
    Phillips, J
    Gorczynski, R
    Levy, GA
    Grant, D
    CIRCULATION, 2005, 112 (02) : 248 - 256
  • [6] Targeted deletion of Fgl2/Fibroleukin in the donor modulates the immunologic response and acute vascular rejection in cardiac xenografts
    Levy, G
    Mendicino, M
    Liu, MF
    Ghanekar, A
    Shalev, I
    Waddell, T
    Phillips, MJ
    Grant, D
    XENOTRANSPLANTATION, 2005, 12 (05) : 381 - 381
  • [7] Fgl-2/fibroleukin-/- cardiac xenografts show features of acute cellular allograft rejection following withdrawal of immunosuppression in a model of accommodation.
    Mendicino, M
    Liu, MF
    He, W
    Phillips, MJ
    Levy, G
    Grant, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 483 - 483
  • [8] Porcine fgl2 activates human prothrombin and is induced in xenogeneic endothelium by acute vascular rejection in vivo and human TNFalpha in vitro
    Ghanekar, A
    Liu, H
    Zhong, R
    Phillips, MJ
    Levy, GA
    Grant, DR
    XENOTRANSPLANTATION, 2003, 10 (05) : 488 - 488
  • [9] Targeted Deletion of FGL2 Leads to Increased Early Viral Replication and Enhanced Adaptive Immunity in a Murine Model of Acute Viral Hepatitis Caused by LCMV WE
    Khattar, Ramzi
    Luft, Olga
    Yavorska, Nataliya
    Shalev, Itay
    Phillips, M. James
    Adeyi, Oyedele
    Gao, Darrin
    Bartczak, Agata
    Urbanellis, Peter
    Shyu, Wendy
    Zhang, Jianhua
    Manuel, Justin
    Levy, Gary A.
    Selzner, Nazia
    PLOS ONE, 2013, 8 (10):
1